All Stories

  1. Induction of immune education in type 1 diabetes through controlled allogeneic islet rejection at onset: a monocentric open-label pilot study
  2. Long-term follow-up of pancreatic islet transplantation in a patient with Wolfram syndrome: a case report
  3. Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 Diabetes
  4. Islet autotransplantation in intraductal papillary mucinous neoplasm: A “Pole Pole” (slowly, slowly) path toward careful expansion of indications
  5. Spheroids Composed of Reaggregated Neonatal Porcine Islets and Human Endothelial Cells Accelerate Development of Normoglycemia in Diabetic Mice
  6. EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents
  7. Roles for the long non-coding RNA Pax6os1/PAX6-AS1 in pancreatic beta cell function
  8. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance
  9. LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
  10. Exploring definitions of graft pancreatitis following pancreas transplantation: A scoping review
  11. Risk factors for bladder injuries during cesarean sections: insights from a 15 year experience at a tertiary care center and a systematic review with meta-analysis
  12. Exploring human pancreatic organoid modelling through single-cell RNA sequencing analysis
  13. Visualization of caudothalamic groove at expert fetal neurosonography
  14. SID/SIEDP expert consensus on optimizing clinical strategies for early detection and management of wolfram syndrome
  15. A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome
  16. Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy
  17. ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care
  18. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
  19. Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation
  20. Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes
  21. Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant
  22. Ketone bodies rescue T cell impairments induced by low glucose availability
  23. Assisted reproductive technology and the risk of fetal congenital heart disease: insights from a tertiary-care referral center
  24. Implications of noncoding regulatory functions in the development of insulinomas
  25. Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes
  26. Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti–Type I Interferon Antibodies
  27. A Case Report of Metastatic Gastric Cancer Treated with Pembrolizumab during Pregnancy
  28. ASO Author Reflections: Bridging the Gap in PDAC Research: The Intraportal Model as a Platform for Studying Preclinical Liver Metastasis
  29. Establishment of a Transplantation Model of PDAC-Derived Liver Metastases
  30. Assisted Reproductive Technology and the risk of Fetal Congenital Heart Disease: insights from a Tertiary Care Referral Centre.
  31. Post-transcriptional regulation of insulin mRNA storage by G3BP1/2+condensates in beta cells
  32. Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions
  33. Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-y Study of the Milan Protocol
  34. A multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.
  35. LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells
  36. Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic β cells
  37. Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity
  38. Improved Specificity of Glutamate Decarboxylase 65 Autoantibody Measurement Using Luciferase-Based Immunoprecipitation System Assays
  39. A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities
  40. AWFS1variant disrupting acceptor splice site uncovers the impact of alternative splicing on β cell apoptosis in a patient with Wolfram syndrome
  41. Proinflammatory Cytokines Suppress Nonsense-Mediated RNA Decay to Impair Regulated Transcript Isoform Processing in Pancreatic β-Cells
  42. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge
  43. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives
  44. IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
  45. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
  46. The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
  47. Legal and Regulatory Challenges for Emerging Regenerative Medicine Solutions for Diabetes
  48. LRH-1/NR5A2 Activation Rewires Immunometabolism Blunting Inflammatory Immune Cell Progression in Individuals with Type 1 Diabetes and Enhances Human Islet Function in Mice
  49. Interleukin‐7 improves the fitness of regulatory T cells for adoptive transfer
  50. Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth
  51. Prevalence of undiagnosed celiac disease in the adult general population of Italy in 1990: Baseline reference for testing current increasing incidence?
  52. Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays
  53. Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
  54. Paediatric Wolfram syndrome Type 1: should gonadal dysfunction be part of the diagnostic criteria?
  55. Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
  56. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry
  57. Reparixin improves survival in critically ill and transplant patients: A meta‐analysis
  58. The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
  59. Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
  60. Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
  61. Pluripotent Stem Cell Therapy for Diabetes
  62. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins
  63. Fat-to-Blood Recirculation of Partially Dysfunctional Pd-1+Cd4 Tconv Cells is Associated with Dysglycemia in Human Obesity
  64. High-Resolution Glucose Fate-Mapping Reveals LDHB-Dependent Lactate Production by Human Pancreatic Islets
  65. Implications of Noncoding Regulatory Functions in the Development of Insulinomas
  66. High-resolution glucose tracing and in situ imaging reveals regulated lactate production in human pancreatic β cells
  67. Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
  68. Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes
  69. Interventional Radiological Management and Prevention of Complications after Pancreatic Surgery: Drainage, Embolization and Islet Auto-Transplantation
  70. Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy
  71. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age
  72. Genetic regulation of RNA splicing in human pancreatic islets
  73. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
  74. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement
  75. Cell Therapy for Type 1 Diabetes: From Islet Transplantation to Stem Cells
  76. Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report
  77. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
  78. Bioengineering the Vascularized Endocrine Pancreas: A Fine-Tuned Interplay Between Vascularization, Extracellular-Matrix-Based Scaffold Architecture, and Insulin-Producing Cells
  79. A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation
  80. A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort
  81. The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
  82. Organoids: a systematic review of ethical issues
  83. In vivo and in vitro characterization of GL0034, a novel long‐acting glucagon‐like peptide‐1 receptor agonist
  84. Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
  85. A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
  86. Ladarixin, an inhibitor of IL ‐8 receptors CXCR1 and CXCR2 , in new‐onset type 1 diabetes: a multicenter, randomized, double‐blind, placebo‐control...
  87. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
  88. Development and evaluation of low-volume tests to detect and characterise antibodies to SARS-CoV-2
  89. Glucose-Dependent miR-125b Is a Negative Regulator of β-Cell Function
  90. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
  91. Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
  92. Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer
  93. Transgenic pigs expressing near infrared fluorescent protein—A novel tool for noninvasive imaging of islet xenotransplants
  94. COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity
  95. Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients
  96. Genetic regulation of RNA splicing in human pancreatic islets
  97. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
  98. Tfh and Tfr Cell Frequency in T1D and Control Subjects
  99. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
  100. The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
  101. Mini‐organs forum: how to advance organoid technology to organ transplant community
  102. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
  103. Correction to: Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy
  104. Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization
  105. Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
  106. Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy
  107. Author Correction: PDX1LOW MAFALOW β-cells contribute to islet function and insulin release
  108. The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
  109. Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2
  110. Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency
  111. US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?
  112. Dysglycemia after COVID-19 pneumonia: a six-month cohort study
  113. Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report
  114. Felix dies natalis, insulin… ceterum autem censeo “beta is better”
  115. Glucose-dependent miR-125b is a negative regulator of β-cell function
  116. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
  117. The microRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
  118. Dysglyceamia after COVID-19 pneumonia: a six-month cohort study.
  119. Preexisting diabetes and COVID-associated hyperglycaemia in patients with COVID-19 pneumonia
  120. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
  121. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene
  122. Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitment and homology with human islets
  123. Total pancreatectomy as alternative to pancreatico-jejunal anastomosis in patients with high fistula risk score: the choice of the fearful or of the wise?
  124. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
  125. Circulating CXCL10 and IL-6 in solid organ donors after brain death predict graft outcomes
  126. Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells
  127. Inhibiting glycolysis rescues memory impairment in an intellectual disability Gdi1-null mouse
  128. COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival
  129. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis
  130. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
  131. A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
  132. PDX1LOW MAFALOW β-cells contribute to islet function and insulin release
  133. Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia
  134. Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene
  135. Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis
  136. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
  137. SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans
  138. Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report
  139. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain
  140. COVID-19 and islet transplantation: Different twins
  141. Rapamycin Plus Vildagliptin to Recover β-Cell Function in Long-Standing Type 1 Diabetes: A Double-Blind, Randomized Trial
  142. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
  143. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study
  144. Autoantibodies Toward ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase Are Reliable Serological Pre-endoscopic Markers of Corpus Atrophic Gastritis
  145. Autoantibodies against type I IFNs in patients with life-threatening COVID-19
  146. The actin modulator hMENA regulates GAS 6‐ AXL axis and pro‐tumor cancer/stromal cell cooperation
  147. Supporting physicians in the management of metabolic alterations in adult kidney transplant recipients: a comment on the joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the I...
  148. Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)
  149. Roles for the long non-coding RNAPax6os1/PAX6-AS1in pancreatic beta cell identity and function
  150. Neonatal diabetes mutations disrupt a chromatin pioneering function that activates the human insulin gene
  151. Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes
  152. Standardized GMP-compliant scalable production of human pancreas organoids
  153. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes
  154. Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children
  155. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma
  156. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]
  157. Gender and Age Effects on the Rates of Infection and Deaths in Individuals with Confirmed SARS-CoV-2 Infection in Six European Countries
  158. Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey Study
  159. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas
  160. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas
  161. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes
  162. Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses
  163. Selective local irradiation improves islet engraftment and survival in intra–bone marrow islet transplantation
  164. Islets for Research: Nothing Is Perfect, but We Can Do Better
  165. CCL 2/ MCP ‐1 and CXCL 12/ SDF ‐1 blockade by L‐aptamers improve pancreatic islet engraftment and survival in mouse
  166. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes
  167. Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
  168. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer
  169. Biofabrication of a vascularized islet organ for type 1 diabetes
  170. Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes
  171. Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice
  172. The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides new insights into the genetics of type 1 diabetes
  173. Diabetes‐free survival after extended distal pancreatectomy and islet auto transplantation for benign or borderline/malignant lesions of the pancreas
  174. Measurement of Autoantibodies to Gastric H+,K+-ATPase (ATP4A/B) Using a Luciferase Immunoprecipitation System (LIPS)
  175. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome
  176. Pluripotent stem cell replacement approaches to treat type 1 diabetes
  177. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
  178. Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study
  179. Differentiation of Sendai virus-reprogrammed iPSC into β cells, compared with human pancreatic islets and immortalized β cell line
  180. Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes
  181. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes
  182. Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology
  183. Human pancreatic islet 3D chromatin architecture provides insights into the genetics of type 2 diabetes
  184. The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
  185. Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells
  186. Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound
  187. No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay
  188. Targeting GLP-1 receptor trafficking to improve agonist efficacy
  189. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes
  190. Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation
  191. The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study
  192. Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology
  193. Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
  194. Defining outcomes for beta cell replacement therapy: a work in progress
  195. Detection and Characterization of CD8+Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes
  196. The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
  197. Proceedings of the signature series event of the international society for cellular therapy: “Advancements in cellular therapies and regenerative medicine in digestive diseases,” London, United Kingdom, May 3, 2017
  198. Anti-Inflammatory Strategies in Intrahepatic Islet Transplantation
  199. A novel LIPS assay for insulin autoantibodies
  200. Minimally Invasive Pancreatectomy plus Islet Autotransplantation for Benign Tumors of the Pancreatic Neck and Body
  201. Islet Cell or Pancreas Transplantation
  202. Islet Cell or Pancreas Transplantation
  203. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells
  204. MiR‐184 expression is regulated by AMPK in pancreatic islets
  205. Bioengineering the Pancreas: Cell-on-Scaffold Technology
  206. Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion
  207. Integrating T cell metabolism in cancer immunotherapy
  208. miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA
  209. A preoperative score to predict early death after pancreatic cancer resection
  210. Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific
  211. Immunological Issues After Stem Cell-Based β Cell Replacement
  212. Modeling the Iatrogenic Pancreatic Cancer Risk After Islet Autotransplantation in Mouse
  213. Pancreatic Islet Transplantation Technologies: State of the Art of Micro- and Macro-Encapsulation
  214. Corrigendum: Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  215. Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation
  216. Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells
  217. Transplant Site Influences the Immune Response After Islet Transplantation
  218. Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation
  219. MP81-15 THE ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN MEN WITH ERECTILE DYSFUNCTION – PRELIMINARY FINDINGS OF A REAL-LIFE CROSS-SECTIONAL STUDY
  220. MP81-20 THE ROLE OF SYSTEMIC INFLAMMATION IN DETERMINING HEALTH STATUS IN MEN WITH SEXUAL DYSFUNCTION – A WORRISOME SCENARIO IN YOUNG MEN
  221. PD13-07 MEN WITH INSULIN RESISTANCE ARE AT INCREASED RISK OF AZOOSPERMIA: RESULTS FROM A CROSS-SECTIONAL STUDY
  222. Salvage Islet Auto Transplantation After Relaparatomy
  223. Stem cells to restore insulin production and cure diabetes
  224. Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks
  225. Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients
  226. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota
  227. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
  228. Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells
  229. MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
  230. Human pancreatic β cell lncRNAs control cell-specific regulatory networks
  231. Abstract A07: Identification of endocrine/metabolic biomarkers associated to early PDC in a transgenic mouse model
  232. Ultra-marathon 100 km in an islet-transplanted runner
  233. Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity
  234. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study
  235. Coxsackie–adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes
  236. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody
  237. Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose
  238. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients
  239. Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma
  240. Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome
  241. V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells
  242. The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas
  243. Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes
  244. Autologous Islet Transplantation in Patients Requiring Pancreatectomy: A Broader Spectrum of Indications Beyond Chronic Pancreatitis
  245. Islet Volume and Indexes of β-Cell Function in Humans
  246. The state of the art of islet transplantation and cell therapy in type 1 diabetes
  247. Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+Stores
  248. Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
  249. Enterovirus strain and type-specific differences in growth kinetics and virus-induced cell destruction in human pancreatic duct epithelial HPDE cells
  250. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells
  251. MR Imaging Monitoring of Iron-Labeled Pancreatic Islets in a Small Series of Patients: Islet Fate in Successful, Unsuccessful, and Autotransplantation
  252. (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
  253. The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions
  254. Hepatic steatosis after islet transplantation: Can ultrasound predict the clinical outcome? A longitudinal study in 108 patients
  255. Islet autotransplantation as a safe procedure in patients with malignancy
  256. Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants
  257. Creation and implantation of acellular rat renal ECM-based scaffolds
  258. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment
  259. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo
  260. Dual-Modal Magnetic Resonance/Fluorescent Zinc Probes for Pancreatic β-Cell Mass Imaging
  261. Diabetes After Pancreatic Surgery: Novel Issues
  262. Human islet distribution programme for basic research: activity over the last 5 years
  263. Calcineurin Inhibitor-Free Immunosuppressive Regimen in Type 1 Diabetes Patients Receiving Islet Transplantation
  264. β-Cell Differentiation of Human Pancreatic Duct–Derived Cells AfterIn VitroExpansion
  265. CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
  266. Isolation, Characterization and Potential Role in Beta Cell-Endothelium Cross-Talk of Extracellular Vesicles Released from Human Pancreatic Islets
  267. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients
  268. Autologous Islet Transplantation in Patients Requiring Pancreatectomy for Neoplasm
  269. The role of insulin in tumor recurrence after resection for pancreatic malignancy. Results of a prospective study
  270. Engraftment Versus Immunosuppression
  271. ADCY5 Couples Glucose to Insulin Secretion in Human Islets
  272. RFamide Peptides 43RFa and 26RFa Both Promote Survival of Pancreatic  -Cells and Human Pancreatic Islets but Exert Opposite Effects on Insulin Secretion
  273. The allocation of pancreas allografts on donor age and duration of intensive care unit stay: the experience of the North Italy Transplant program
  274. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants
  275. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection
  276. Relaparotomy for a pancreatic fistula after a pancreaticoduodenectomy: a comparison of different surgical strategies
  277. Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm
  278. Effects of exercise in a islet-transplanted half-marathon runner: outcome on diabetes management, training and metabolic profile
  279. Autologous Pancreatic Islet Transplantation in Human Bone Marrow. Diabetes 2013;62:3523-3531
  280. Liver Perfusion Changes Occurring During Pancreatic Islet Engraftment: A Dynamic Contrast-Enhanced Magnetic Resonance Study
  281. Human Pancreatic Islet Preparations Release HMGB1: (Ir)Relevance for Graft Engraftment
  282. β-cell transplantation in diabetes mellitus
  283. Rapamycin unbalances the polarization of human macrophages to M1
  284. Islet Transplantation Stabilizes Hemostatic Abnormalities and Cerebral Metabolism in Individuals With Type 1 Diabetes
  285. Lipotoxicity disrupts incretin-regulated human β cell connectivity
  286. Anti-Inflammatory Strategies to Enhance Islet Engraftment and Survival
  287. Extending Indications for Islet Autotransplantation in Pancreatic Surgery
  288. Autologous Pancreatic Islet Transplantation in Human Bone Marrow
  289. A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma (mPA)
  290. Mass spectrometric analysis reveals O-methylation of pyruvate kinase from pancreatic cancer cells
  291. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets
  292. Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction
  293. Murine animal models for preclinical islet transplantation
  294. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
  295. Homeostatic T Cell Proliferation after Islet Transplantation
  296. Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
  297. Autologous islet transplantation to improve glycaemic control following extended pancreatectomy: indications and outcome
  298. Immunomodulation of CXCR2 Improves the Islet Engraftment and Survival after Liver Infusion
  299. Influenza A Viruses Grow in Human Pancreatic Cells and Cause Pancreatitis and Diabetes in an Animal Model
  300. Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma
  301. CXCR1/2 inhibition enhances pancreatic islet survival after transplantation
  302. Human β Cell Transcriptome Analysis Uncovers lncRNAs That Are Tissue-Specific, Dynamically Regulated, and Abnormally Expressed in Type 2 Diabetes
  303. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction
  304. MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells
  305. No evidence of enteroviruses in the intestine of patients with type 1 diabetes
  306. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
  307. Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification
  308. Des-Acyl Ghrelin Fragments and Analogues Promote Survival of Pancreatic β-Cells and Human Pancreatic Islets and Prevent Diabetes in Streptozotocin-Treated Rats
  309. Proteomic Analysis Reveals Warburg Effect and Anomalous Metabolism of Glutamine in Pancreatic Cancer Cells
  310. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up
  311. Comparative Evaluation of Simple Indices of Graft Function After Islet Transplantation
  312. Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
  313. Alternative Transplantation Sites for Pancreatic Islet Grafts
  314. Therapeutic plasticity of stem cells and allograft tolerance
  315. Fatty liver index and mortality: The cremona study in the 15th year of follow-up
  316. Proteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Metabolic Alterations
  317. Ask The Experts: Challenges and prospects for stem cell-based therapy in Type 1 diabetes
  318. Phosphoproteomic Analysis of Pancreatic Ductal Adenocarcinoma Cells Reveals Differential Phosphorylation of Cell Adhesion, Cell Junction and Structural Proteins
  319. Risks and Benefits of Transplantation in the Cure of Type 1 Diabetes: Whole Pancreas Versus Islet Transplantation. A Single Center Study
  320. Bone Marrow and Pancreatic Islets: An Old Story With New Perspectives
  321. Beta cell function during rapamycin monotherapy in long-term type 1 diabetes
  322. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study
  323. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: Implications for pathogenesis
  324. Role of CCL2/MCP-1 in Islet Transplantation
  325. ISLET CELL TRANSPLANTS FAIL DUE TO DONOR SPECIFIC ANTIBODIES
  326. Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
  327. Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice
  328. Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
  329. Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function
  330. A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals
  331. Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
  332. Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes
  333. Mesenchymal Stem Cells as Feeder Cells for Pancreatic Islet Transplants
  334. The Pancreatic Lymph-nodes of Type 1 Diabetic Patients Contain Epigenetically-imprinted Natural Regulatory T Cells which Lack Suppressive Function
  335. Improving the Procedure for Detection of Intrahepatic Transplanted Islets by Magnetic Resonance Imaging
  336. Bone marrow as an alternative site for islet transplantation
  337. Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
  338. Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans
  339. The contribution of hematopoietic stem cells to beta-cell replacement
  340. Mesenchymal Cells Appearing in Pancreatic Tissue Culture are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function
  341. Ghrelin-producing epsilon cells in the developing and adult human pancreas
  342. Intrahepatic Islet Transplant in the Mouse: Functional and Morphological Characterization
  343. The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
  344. β-cell transplantation for diabetes therapy
  345. Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells
  346. High Levels of Donor CCL2/MCP-1 Predict Graft-Related Complications and Poor Graft Survival After Kidney-Pancreas Transplantation
  347. Diabetes mellitus: an opportunity for therapy with stem cells?
  348. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells
  349. Transplant Estimated Function: A simple index to evaluate  -cell secretion after islet transplantation
  350. A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer
  351. Relevance of Hyperglycemia on the Timing of Functional Loss of Allogeneic Islet Transplants: Implication for Mouse Model
  352. Culture Medium Modulates Proinflammatory Conditions of Human Pancreatic Islets Before Transplantation
  353. Increased intestinal permeability precedes clinical onset of type 1 diabetes
  354. Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin
  355. Rapamycin Induces a Caspase-Independent Cell Death in Human Monocytes
  356. Stem Cells and the Kidney: A New Therapeutic Tool?
  357. Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
  358. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
  359. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4
  360. Donor and Isolation Variables Associated with Human Islet Monocyte Chemoattractant Protein-1 Release
  361. Tissue Factor and CCL2/Monocyte Chemoattractant Protein-1 Released by Human Islets Affect Islet Engraftment in Type 1 Diabetic Recipients
  362. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile
  363. Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell
  364. In vitro modulation of monocyte chemoattractant protein-1 release in human pancreatic islets
  365. From Pattern Recognition Receptor to Regulator of Homeostasis: The Double-Faced Macrophage Mannose Receptor
  366. Cross-Linking of the Mannose Receptor on Monocyte-Derived Dendritic Cells Activates an Anti-Inflammatory Immunosuppressive Program
  367. Fasting Plasma Leptin, Tumor Necrosis Factor-  Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant Women: Impact on cardiovascular mortality
  368. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells
  369. Rapamycin impairs antigen uptake of human dendritic cells1
  370. Strategies for tumor immune escape
  371. Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation
  372. Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability
  373. Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells
  374. EFFECTS OF CRYOPRESERVATION ON IN VITRO AND IN VIVO LONG-TERM FUNCTION OF HUMAN ISLETS1
  375. CRYOPRESERVATION OF HUMAN ISLETS OF LANGERHANS
  376. Glucocorticoids increase the endocytic activity of human dendritic cells
  377. Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells
  378. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
  379. Islet transplantation in IDDM patients
  380. Glucagon improves insulin secretion from pig islets in vitro
  381. Isolation and function of adult pig Islets
  382. Gluten-Free Diet in Subjects at Risk for Type 1 Diabetes: A Tool for Delaying Progression to Clinical Disease?